Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEHIM_CCRT phase II trial of definitive hypofractionated IMRT with concurrent cisplatin for cervical cancer
KCT0010935Phase 2Recruiting
- Sponsor
- Samsung Medical Center
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin in Cervical Cancer (CC), sponsored by Samsung Medical Center. Started Dec 2025; status: recruiting.
02
Drugs
cisplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on KCT0010935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0010935.